Cargando…
Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
Acute respiratory distress syndrome (ARDS) is a serious condition that can arise following direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate. Supportive care is the mainstay of treatment and there is no definitive pharmacological treatment as yet. In noncl...
Autores principales: | Ding, Qiongli, Wang, Yi, Yang, Chunbo, Li, Xiang, Yu, Xiangyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412801/ https://www.ncbi.nlm.nih.gov/pubmed/36911225 http://dx.doi.org/10.1007/s44231-022-00012-5 |
Ejemplares similares
-
Effect of Sivelestat in the Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis
por: Ding, Qiongli, et al.
Publicado: (2023) -
Detection of sivelestat and its metabolite in small volumes of plasma from Chinese ALI/ARDS patients with SIRS via high-throughput UPLC-MS/MS: A pharmacokinetic study
por: Liu, Mingzhou, et al.
Publicado: (2021) -
Advances in the use of exosomes for the treatment of ALI/ARDS
por: Liu, Chang, et al.
Publicado: (2022) -
Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients
por: Miyoshi, Seigo, et al.
Publicado: (2014) -
The Role of Macrophages in the Pathogenesis of ALI/ARDS
por: Huang, Xiaofang, et al.
Publicado: (2018)